BLOC1S3 and cancer: Together, the effective targeting of ribosome biogenesis and protein synthesis may prove effective in overcoming growth signaling pathway redundancies and tumor heterogeneity and can potentially be used for the treatment of a large subset of human cancer with RP gene deletions.25